EFM-20467-90018
1 vaccination
3 coded responses
7 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 208 / MD
- Registered
- 2021-02-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Moderna
-
2021-02-14
Registered in v-safe
- 2021-02-15
- 2021-02-22
-
2021-03-01
Survey response — day 35, dose 1MedDRA: Anxiety, Normetanephrine urine increased, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Continue to have episodes of tachycardia and now I am having anxiety attacks. The levels of normetanephrine are also increasedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Report sent to call center — day 35, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-08
- 2021-04-26
-
2021-07-26
Survey response — 6 months, dose 1MedDRA: Alopecia, Hepatic enzyme increased — Feeling: GoodFree text: Generalized Hair loss, increased liver enzymesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-28
-
2022-01-25
Survey response — 12 months, dose 1MedDRA: Alopecia, Autonomic nervous system imbalance, Dizziness, Dyspnoea, Hepatic enzyme abnormal, Neurologic somatic symptom disorder, Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: I was diagnosed with an immune neurologic process with dysautomia and nervous alter. Tinnitus still present, liver enzymes are now within normal but on the high side, continue with occasional SOB and dizziness. Hair loss is more under controlMedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Moderna |
Call center
2 call center cases
2 unsuccessful
VAERS report filed, before or during a call: 2
1 wait over 3 months for a first call
Free text
Release 4 — day 35, dose 1
Symptoms: Continue to have episodes of tachycardia and now I am having anxiety attacks. The levels of normetanephrine are also increased
Release 9 — 6 months, dose 1
Symptoms: Generalized Hair loss, increased liver enzymes
Release 11 — 12 months, dose 1
Symptoms: I was diagnosed with an immune neurologic process with dysautomia and nervous alter. Tinnitus still present, liver enzymes are now within normal but on the high side, continue with occasional SOB and dizziness. Hair loss is more under control
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | ✓ | · | ✓ |
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Autonomic nervous system imbalance | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Hepatic enzyme abnormal | · | · | ✓ |
| SD | Hepatic enzyme increased | ✓ | · | ✓ |
| SD | Neurologic somatic symptom disorder | · | · | ✓ |
| SD | Normetanephrine urine increased | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SD | Tinnitus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release